Dora ha scritto: ↑martedì 9 luglio 2024, 5:18Come da tradizione, a inizio AIDS 2024, il 22 luglio, UNAIDS presenterà un report su nuovi dati, che dovrebbero dimostrare la possibilità di raggiungere l'obiettivo della "fine dell'AIDS" entro il 2030 - da intendersi come "la fine dell'AIDS come minaccia alla salute pubblica": The Urgency of Now: AIDS at a Crossroads.
Naturalmente questo è subordinato alle decisioni che i leader mondiali prenderanno quest'anno riguardo ai finanziamenti e alle restrizioni dei diritti umani.
[...]
Con una PrEP che funziona in questo modo, un vaccino diventa molto meno necessario. Sempre che i leader mondiali cui UNAIDS fa riferimento siano disponibili a trovare le risorse per far arrivare il lenacapavir in ogni megalopoli dell'Asia e in ogni sperduto villaggio dell'Africa.
Con tutte le altre crisi mondiali che funestano questi anni, un'ipotesi che pare destinata a rimanere un wishful thinking.
Ieri UNAIDS ha presentato il suo report:
Comunicato stampa
Presentazione a AIDS 2024
https://www.youtube.com/watch?v=RlQyDl_G1Mk
PDF completo del report: The Urgency of Now: AIDS at a Crossroads — 2024 global AIDS update
Exexutive summary e fact sheet
Global HIV & AIDS statistics — Fact sheet
Global HIV statistics
39.9 million [36.1 million–44.6 million] people globally were living with HIV in 2023.
1.3 million [1 million–1.7 million] people became newly infected with HIV in 2023.
630 000 [500 000–820 000] people died from AIDS-related illnesses in 2023.
30.7 million people [27–31.9 million] were accessing antiretroviral therapy in 2023.
88.4 million [71.3 million–112.8 million] people have become infected with HIV since the start of the epidemic.
42.3 million [35.7 million–51.1 million] people have died from AIDS-related illnesses since the start of the epidemic
People living with HIV
In 2023, there were 39.9 million [36.1 million–44.6 million] people living with HIV.
38.6 million [34.9 million–43.1 million] adults (15 years or older).
1.4 million [1.1 million–1.7 million] children (0–14 years).
53% of all people living with HIV were women and girls.
86% [69–>98%] of all people living with HIV knew their HIV status in 2023.
About 5.4 million people did not know that they were living with HIV in 2023.
People living with HIV accessing antiretroviral therapy
At the end of December 2023, 30.7 million [27–31.9 million] people were accessing antiretroviral therapy, up from 7.7 million [6.7–8 million] in 2010, but still short of the 34 million target for 2025.
In 2023, 77% [61–89%] of all people living with HIV were accessing treatment.
77% [62–90%] of adults aged 15 years and older living with HIV had access to treatment, as did 57% [41–75%] of children aged 0–14 years.
83% [66–96%] of women aged 15 years and older had access to treatment; however, just 72% [56–84%] of men aged 15 years and older had access.
84% [72–>98%] of pregnant women living with HIV had access to antiretroviral medicines to prevent transmission of HIV to their child in 2023.
New HIV infections
New HIV infections have been reduced by 60% since the peak in 1995.
In 2023, 1.3 million [1 million–1.7 million] people were newly infected with HIV, compared to 3.3 million [2.6 million–4.2 million] people in 1995.
Women and girls accounted for 44% of all new infections in 2023.
Since 2010, new HIV infections have declined by 39%, from 2.1 million [1.7 million–2.7 million] to 1.3 million [1 million–1.7 million] in 2023. However, this falls far short of the target of getting below 370 000 by 2025.
Since 2010, new HIV infections among children have declined by 62%, from 300 000 [220 000–440 000] in 2010 to 120 000 [83 000–170 000] in 2023. Although progress in reducing new HIV infections is greatest among children, progress has stalled in recent years.
AIDS-related deaths
AIDS-related deaths have been reduced by 69% since the peak in 2004 and by 51% since 2010.
In 2023, around 630 000 [500 000–820 000] people died from AIDS-related illnesses worldwide, compared to 2.1 million [1.6 million–2.7 million] people in 2004 and 1.3 million [1 million–1.7 million] people in 2010.
The target for 2025 is fewer than 250 000.
AIDS-related mortality has declined by 56% among women and girls and by 47% among men and boys since 2010.
In 2023, someone died of HIV every minute.
People most affected by HIV
Median HIV prevalence among the adult population (ages 15–49) was 0.8% globally. However, because of marginalization, discrimination and in some cases criminalization, median prevalence was higher among certain groups of people.
2.3% higher among young women and girls aged between 15 and 24 in eastern and southern Africa
7.7% higher among gay men and other men who have sex with men
3% higher among sex workers
5% higher among people who inject drugs
9.2% higher among transgender people
1.3% higher among people in prisons.
Women and girls
Globally 44% of all new HIV infections were among women and girls (all ages) in 2023.
In sub-Saharan Africa, women and girls (all ages) accounted for 62% of all new HIV infections. In all other geographical regions, over 73% of new HIV infections in 2023 occurred among men and boys.
Every week, 4000 adolescent girls and young women aged 15–24 years became infected with HIV globally in 2023. 3100 of these infections occurred in sub-Saharan Africa.
Testing and treatment targets (95–95–95)
In 2023, 86% [69–>98%] of all people living with HIV knew their HIV status. Among people who knew their status, 89% [71–>98%] were accessing treatment. And among people accessing treatment, 93% [74–>98%] were virally suppressed.
Among children ages 0–14 years the 95–95–95 targets were 66% [47%–87%], 86% [62%–>98%], 84% [60%–>98%] Among women, the 95–95–95 targets were: 91% [72–>98%], 91% [73–>98%], and 94% [75–>98%].
Among men, the 95–95–95 targets were: 83% [65–97%] of adult men living with HIV knew their HIV status, 86% [68–>98%] were accessing treatment and 94% [74–>98%] were virally suppressed.
Among all people living with HIV, 86% [69–>98%] knew their status, 77% [61–89%] were accessing treatment and 72% [65–80%] were virally suppressed in 2023.
Investments
At the end of 2023, US$ 19.8 billion (in constant 2019 United States dollars) was available for the AIDS response in low- and middle-income countries—around 59% was from domestic sources.
Funding for HIV dropped by 5% from 2022 to 2023, and by 7.9% between 2020 and 2023.
Funding is far short of the US$ 29.3 billion (in constant 2019 United States dollars) which will be required for the AIDS response in low- and middle-income countries, including countries formerly considered to be upper-income countries, in 2025 to get on track to end AIDS as a public health threat.
)